Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA

The Lancet

Volumn 335, Issue 8680, 1990, Pages 11-15

  Lucey, M R ^a   Kolars, J C ^a   Merion, R M ^a   Campbell, D A ^a   Aldrich, M ^a   Watkins, P B ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYTOCHROME P450; RIFAMPICIN;

ARTICLE; BLOOD LEVEL; BREATH ANALYSIS; CASE REPORT; HUMAN; KIDNEY FAILURE; LIVER TRANSPLANTATION; MALE; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; PROVOCATION TEST;

ADMINISTRATION, ORAL; ADULT; BREATH TESTS; CARBON RADIOISOTOPES; CASE REPORT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINS; CYTOCHROME P-450 ENZYME SYSTEM; ERYTHROMYCIN; EVALUATION STUDIES; HUMAN; IMMUNOBLOTTING; ISOENZYMES; LIVER TRANSPLANTATION; MALE; MICROSOMES, LIVER; RIFAMPIN; STIMULATION, CHEMICAL; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0025058297     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(90)90137-T     Document Type: Article

References (23)

1. Optimization of cyclosporine therapy in renal transplantation by a pharmacokinetic strategy
2. Central nervous system toxicity after liver transplantation the role of cyclosporine and cholesterol
3. Metabolites of cyclosporine
4. Cyclosporine metabolism in human liver identification of a cytochrome P-450 III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs
5. Erythromycin breath test as an assay of glucocorticoid inducible liver cytochromes P-450: studies in rats and patients
6. Metabolism of cyclosporin A IV: purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily
7. Purification of a human liver cytochrome P-450 immunochemically related to several cytochromes P-450 purified from untreated rats
8. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism
9. Identification of an inducible form of cytochrome P-450 in human liver
10. Ligand chromatographic analysis of cyclosporine with use of a micropore column and small sample size
11. Genetically determined polymorphisms in drug oxidation
12. Polymorphic hydroxylation of debrisoquine in man
13. Characterization of the common genetic defect in humans defident in debrisoquine metabolism
14. Impaired oxidation of debrisoquine in patients with perhexiline liver injury
15. Hormones and resistance
16. Differential effects of beta-naphthoflavone and pregnenolone-16α-carbonitrile on dimethylnitrosamine-induced hepatocarcinogenesis
17. Cyclosporin A pharmacokinetics in liver transplant recipients in relation to biliary T-tube clamping and liver dysfunction
18. Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man
19. P-450 III metabolizes cyclosporin A in intestinal mucosa: observations in a novel rat model
20. Absorption of cyclosporin from rabbit small intestine in situ
21. Induction of microsomal cytochrome P-450 enzymes: the first Bernard B. Brodie lecture at Pennsylvania State University
22. Clinical significance of the sparteine/debrisoquine oxidation polymorphism